ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,149.78
0.16%
Dow Jones
42,992.21
-0.77%
Gold vs US Dollar
2,622.18
0.00%
Brent Oil
73.44
0.00%
Bitcoin
94,349.61
0.20%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Halozyme Therapeutics Incorporated (HALO) Share Price

HALO Halozyme Therapeutics Incorporated

48.4693
0.4393 (0.91%)
28 Dec 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Halozyme Therapeutics Incorporated NASDAQ:HALO NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.4393 0.91 48.4693 47.50 48.50 48.26 47.56 47.6 946,090 01:00:00   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Biological Pds,ex Diagnstics 829.25M 281.59M 2.2133 21.75 6.11B
 Type  Size  Price  Time  Units 
 9 1 48.13 00:33:43 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore HALO News
03/12/202421:05EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
03/12/202421:04EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
27/11/202413:30PRNUSHalozyme to Present at Upcoming Investor Conferences
22/11/202413:35PRNUSHalozyme Withdraws Proposal to Acquire Evotec Following Evotec's Unwillingness to Engage in Discussions
14/11/202421:15PRNUSHalozyme Confirms Proposal to Combine with Evotec for €11.00 Per Share in an All-Cash Transaction
12/11/202414:36EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
31/10/202420:05EDGAR2Form 8-K - Current report
Period
Draw mode
Latest Message Board Discussions
DateTimeSource
Title
Posts
14/02/201908:08PBBRECOVERY STOCK @ 17.25p WITH BROKER TARGET OF 40p - HALOSOURCE (HALO)367
26/01/201511:01PBBHalosource - Clean water tech583
05/11/201410:17PBBGary Middleton, Director Lothbury Financial Services says to BUY in Halosource 2
10/04/201412:41PBBDO YOU OWN A SWIMMING POOL OR HOT TUB ?2
Data Downloads for HALO

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Halozyme Therapeutics Incorporated Articles

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads